Source: BioSpace

Neuraltus: Neuraltus Pharmaceuticals, Inc. And The University of Hawaii At Manoa Announce Initiation Of Phase Ib Study Of NP001 In Patients With Mild-To-Moderate Alzheimer's Disease

Life Sciences Jobs ...

Read full article »
Neuraltus's Competitors | Neuraltus's News | Neuraltus's Financials
Stay up-to-date with the latest news on Neuraltus
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Richard L. Casey's photo - President & CEO of Neuraltus

President & CEO

Richard L. Casey

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Neuraltus